학술논문
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
Document Type
Article
Author
Source
In Annals of Oncology November 2012 23(11):2834-2842
Subject
Language
ISSN
0923-7534